Injection, Suspension · Intramuscular

Influenza A Virus A/Georgia/12/2022 Cvr-167 (H1n1) Antigen (Mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/Victoria/800/2024 Cvr-289 (H3n2) Antigen (Mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/Singapore/Wuh4618/2021 Antigen (Mdck Cell Derived, Propiolactone Inactivated)

Brands: Flucelvax · Influenza A Virus A/Georgia/12/2022 Cvr-167 (H1n1) Antigen (Mdck Cell Derived, Propiolactone Inactivated) + Influenza A Virus A/Victoria/800/2024 Cvr-289 (H3n2) Antigen (Mdck Cell Derived, Propiolactone Inactivated) + Influenza B Virus B/Singapore/Wuh4618/2021 Antigen (Mdck Cell Derived, Propiolactone Inactivated)

0 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US1 NDCs
0 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)1657128

US makers1 labelers

Packages1

DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it0 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Bamboo US BidCo LLC	unknown	1	EXITED 2026

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.